Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02519023 · ClinicalTrials.gov registry record · Phase 4
TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy
A Phase 4 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 87
- Enrollment target
NCT02519023 is a Phase 4 study that has completed, run by University of Minnesota. The registered enrollment target is 87 participants.
The verdict
NCT02519023, a Phase 4 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 87 participants
- Enrollment target
Study Summary
Laparoscopic and Robotic assisted hysterectomy is a surgical procedure that is a minimally invasive way in which to remove the uterus, which has less scarring and fewer complications. However, this procedure, much like its open-surgical counterpart, is often associated with significant post-operative pain. To augment this pain there are many different analgesic techniques available to offset pain. Ultrasound-guided transversus abdominis plane (TAP) block is one such procedure involving the injection of a local anesthetic into the plane of the transversus abdominal muscle where the terminal branches of nerves lie. A similar, yet different analgesic approach is that of direct injection of local anesthetic into the incision by the surgeon during or just after surgical procedures. These two approaches have both been proven to decrease post-operative pain in patients for many procedures, but never compared to one another.
Interventions
- DRUG Bupivacaine
- DRUG Liposomal Bupivacaine
- DRUG Epinephrine
- DEVICE Ultrasound
- DRUG acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02519023
The ClinicalTrials.gov registry entry for NCT02519023 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupivacaine is the first listed.
NCT02519023 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02519023 about?
NCT02519023 is a clinical study titled "TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy". Laparoscopic and Robotic assisted hysterectomy is a surgical procedure that is a minimally invasive way in which to remove the uterus, which has less scarring and fewer complications. However, this procedure, much like its open-surgical counterpart, is often associated with significant post-operativ...
What is the current status of trial NCT02519023?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 87 participants. The study started on 2016-07. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02519023?
The interventions under investigation include: Bupivacaine (DRUG), Liposomal Bupivacaine (DRUG), Epinephrine (DRUG), Ultrasound (DEVICE), acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02519023?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.